Cheriyan Group · Cambridge University Hospitals · University of Cambridge
Dr Joseph Cheriyan — Cambridge Clinical Research Group
Dr Joseph Cheriyan (MBChB, MA, FRCP, FESC, FACC) leads a clinical research group at Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge. The group evaluates novel and repurposed therapeutics in humans — from first-in-human safety through Phase I/II proof-of-efficacy trials — with a particular focus on cardiovascular medicine (hypertension, heart failure, acute coronary syndromes, dyslipidaemia and vascular inflammation) and respiratory medicine (COPD, COVID-19).
IGNITE — Innovative Group for Novel Interventions, Trials & Experimental Medicine
The group's AI, digital-biomarker and technology-enabled trial work is delivered through IGNITE, its Cambridge programme applying artificial intelligence, wearable sensors, digital biomarkers and adaptive trial methodologies to cardiovascular disease detection, monitoring and treatment.
Cardiovascular Trials Office and Research Echo Service
The group operates the Cardiovascular Trials Office at Cambridge and the Research Echo Service, providing sponsors, CROs and academic collaborators with sponsor-grade cardiac echocardiography, imaging, biomarker measurement and trial delivery services for early-phase and pivotal studies.
Explore the site
This page requires JavaScript for the full interactive experience. Enable JavaScript in your browser, or follow the links above.